Dean Jarnac - 15 Feb 2022 Form 4 Insider Report for Marvell Technology, Inc. (MRVL)

Role
EVP Worldwide Sales
Signature
Dean Jarnac by Blair Walters as Attorney-in-Fact
Issuer symbol
MRVL
Transactions as of
15 Feb 2022
Transactions value $
-$16,021
Form type
4
Filing time
17 Feb 2022, 12:46:39 UTC
Previous filing
19 Jan 2022
Next filing
17 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRVL Common Stock Options Exercise $0 +434 +0.85% $0.00 51.5K 15 Feb 2022 Direct
transaction MRVL Common Stock Tax liability -$16K -216 -0.42% $74.17 51.3K 15 Feb 2022 Direct F1
holding MRVL Common Stock 30.9K 15 Feb 2022 By Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRVL Restricted Stock Units Options Exercise $0 -434 -100% $0.00* 0 15 Feb 2022 Common Stock 434 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Surrender of shares in payment of tax withholding due as a result of the vesting of restricted stock units ("RSUs").
F2 Shares are held in a revocable trust. Dean and Megan Jarnac are trustees of the trust, of which their children are the beneficiaries.
F3 Each RSU represents a contingent right to receive one Marvell Technology, Inc. common share upon vesting.
F4 This award fully vested on February 15, 2022.